Jones Financial Companies, L.L »

Silence Therapeutics shares owned by Jones Financial Companies, L.L

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Jones Financial Companies, L.L from 13F filings

Historical chart of Jones Financial Companies, L.L investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Jones Financial Companies, L.L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Jones Financial Companies, L.L

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 2.5k 5.54
2025-06-30 $15k 2.5k 5.79
2025-03-31 $8.6k 2.5k 3.44

More positions owned by Jones Financial Companies, L.L

Vanguard Index Tr ETFs (VUG)
Ishares Core Us Aggregate Bond ETFs (AGG)
Ishares Core S&p 500 Etf ETFs (IVV)
Vanguard Index Tr ETFs (VTV)
Vanguard S&p 500 Etf ETFs (VOO)
Ishares Trust Core Msci Eafe ETFs (IEFA)
Ishares Russell Midcap ETFs (IWR)
Vanguard Mid Cap Etf ETFs (VO)
Vanguard Index Trust ETFs (VV)
Ishares Russell 1000 ETFs (IWB)
Spdr Portfolio Large Cap Etf ETFs (SPLG)
Ishares Core Total Usd Bond ETFs (IUSB)
Vanguard Ftse Developed ETFs (VEA)
Ishares Broad Usd High Yield ETFs (USHY)
Ishares Core S&p Small Cap Etf ETFs (IJR)

View all positions for Jones Financial Companies, L.L

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Morgan Stanley
Vivo Capital
Nantahala Capital Management
Frazier Life Sciences Management
Nextech Invest
Ikarian Capital
Cantor Fitzgerald, L. P.
5AM Venture Management
SG Americas Securities
UBS Group
Millennium Management

View all funds holding Silence Therapeutics